Mangalam Current Deferred Revenue from 2010 to 2024

Stocks . India . 
Stock . Mangalam Drugs And
MANGALAM   111.44  3.17  2.77%   
Mangalam Drugs' Current Deferred Revenue is increasing over the years with slightly volatile fluctuation. Overall, Current Deferred Revenue is expected to go to about 63.7 M this year. Current Deferred Revenue is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. View All Fundamentals
 
Current Deferred Revenue  
First Reported
2010-12-31
Previous Quarter
46.6 M
Current Value
63.7 M
Quarterly Volatility
36.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mangalam Drugs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mangalam Drugs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 153.8 M, Interest Expense of 79.1 M or Selling General Administrative of 410.2 M, as well as many indicators such as . Mangalam financial statements analysis is a perfect complement when working with Mangalam Drugs Valuation or Volatility modules.
  
This module can also supplement various Mangalam Drugs Technical models . Check out the analysis of Mangalam Drugs Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CCitigroup
GMGeneral Motors
FFord Motor

Other Information on Investing in Mangalam Stock

Mangalam Drugs financial ratios help investors to determine whether Mangalam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mangalam with respect to the benefits of owning Mangalam Drugs security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY